These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 10653223)

  • 1. Olanzapine serum concentrations lowered by concomitant treatment with carbamazepine.
    Licht RW; Olesen OV; Friis P; Laustsen T
    J Clin Psychopharmacol; 2000 Feb; 20(1):110-2. PubMed ID: 10653223
    [No Abstract]   [Full Text] [Related]  

  • 2. Free and glucuronidated olanzapine serum concentrations in psychiatric patients: influence of carbamazepine comedication.
    Linnet K; Olesen OV
    Ther Drug Monit; 2002 Aug; 24(4):512-7. PubMed ID: 12142636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of olanzapine on polydipsia and intermittent hyponatremia.
    Littrell KH; Johnson CG; Littrell SH; Peabody CD
    J Clin Psychiatry; 1997 Dec; 58(12):549. PubMed ID: 9448660
    [No Abstract]   [Full Text] [Related]  

  • 4. Severe hypertriglyceridemia associated with olanzapine.
    Stoner SC; Dubisar BM; Khan R; Farrar CD
    J Clin Psychiatry; 2002 Oct; 63(10):948-9. PubMed ID: 12416606
    [No Abstract]   [Full Text] [Related]  

  • 5. Continuing treatment with novel antipsychotic drugs despite leukopenia or thrombocytopenia.
    Jackson RS
    Arch Gen Psychiatry; 2001 Jul; 58(7):706-7. PubMed ID: 11448379
    [No Abstract]   [Full Text] [Related]  

  • 6. Healthy outcome under olanzapine treatment in a pregnant woman.
    Kirchheiner J; Berghöfer A; Bolk-Weischedel D
    Pharmacopsychiatry; 2000 Mar; 33(2):78-80. PubMed ID: 10761825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Olanzapine-induced neuroleptic malignant syndrome.
    Burkhard PR; Vingerhoets FJ; Alberque C; Landis T
    Arch Gen Psychiatry; 1999 Jan; 56(1):101-2. PubMed ID: 9892264
    [No Abstract]   [Full Text] [Related]  

  • 8. Tardive dystonia associated with olanzapine therapy.
    Gunal DI; Onultan O; Afsar N; Aktan S
    Neurol Sci; 2001 Aug; 22(4):331-2. PubMed ID: 11808858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pharmacokinetic interaction between carbamazepine and olanzapine: observations on possible mechanism.
    Lucas RA; Gilfillan DJ; Bergstrom RF
    Eur J Clin Pharmacol; 1998 Oct; 54(8):639-43. PubMed ID: 9860152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of olanzapine plasma concentrations on depressive symptoms in schizophrenia: a pilot study.
    Lane HY; Guo SC; Hwang TJ; Chen YS; Cheng JJ; Lee YC; Hong CJ; Hwu HG; Chang WH
    J Clin Psychopharmacol; 2002 Oct; 22(5):530-2. PubMed ID: 12352282
    [No Abstract]   [Full Text] [Related]  

  • 11. Tardive dyskinesia associated with olanzapine monotherapy.
    Ananth J; Kenan J
    J Clin Psychiatry; 1999 Dec; 60(12):870. PubMed ID: 10665640
    [No Abstract]   [Full Text] [Related]  

  • 12. Olanzapine and pregnancy.
    Dickson RA; Dawson DT
    Can J Psychiatry; 1998 Mar; 43(2):196-7. PubMed ID: 9533978
    [No Abstract]   [Full Text] [Related]  

  • 13. Propranolol treatment of olanzapine-induced akathisia.
    Kurzthaler I; Hummer M; Kohl C; Miller C; Fleischhacker WW
    Am J Psychiatry; 1997 Sep; 154(9):1316. PubMed ID: 9286196
    [No Abstract]   [Full Text] [Related]  

  • 14. Case report: possible neuroleptic malignant syndrome associated with olanzapine.
    Moltz DA; Coeytaux RR
    J Clin Psychopharmacol; 1998 Dec; 18(6):485-6. PubMed ID: 9864084
    [No Abstract]   [Full Text] [Related]  

  • 15. Case report of withdrawal syndrome after olanzapine discontinuation.
    Nayudu SK; Scheftner WA
    J Clin Psychopharmacol; 2000 Aug; 20(4):489-90. PubMed ID: 10917413
    [No Abstract]   [Full Text] [Related]  

  • 16. Olanzapine for the treatment of monosymptomatic hypochondriacal psychosis.
    Fawcett RG
    J Clin Psychiatry; 2002 Feb; 63(2):169. PubMed ID: 11874224
    [No Abstract]   [Full Text] [Related]  

  • 17. Neuroleptic malignant syndrome after the initiation of olanzapine.
    Levenson JL
    J Clin Psychopharmacol; 1999 Oct; 19(5):477-8. PubMed ID: 10505593
    [No Abstract]   [Full Text] [Related]  

  • 18. Instability of olanzapine in calf serum.
    Lakso HA
    Ther Drug Monit; 2001 Aug; 23(4):454-5. PubMed ID: 11477333
    [No Abstract]   [Full Text] [Related]  

  • 19. Topiramate produced weight loss following olanzapine-induced weight gain in schizophrenia.
    Levy E; Margolese HC; Chouinard G
    J Clin Psychiatry; 2002 Nov; 63(11):1045. PubMed ID: 12469686
    [No Abstract]   [Full Text] [Related]  

  • 20. Acute dystonia with olanzapine.
    Landry P; Cournoyer J
    J Clin Psychiatry; 1998 Jul; 59(7):384. PubMed ID: 9714272
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.